Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)-Reference-Cited by-同舟云学术

Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Published:2023-06-23 Issue:8 Volume:34 Page:1283-1299
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Moon Rebecca J.^ORCID,Reginster Jean-Yves^ORCID,Al-Daghri Nasser M.^ORCID,Thiyagarajan Jotheeswaran A.,Beaudart Charlotte^ORCID,Bruyère Olivier^ORCID,Burlet Nansa,Chandran Manju,da Silva Mario Coelho,Conaghan Philip G.^ORCID,Dere Willard H.^ORCID,Diez-Perez Adolfo,Hadji Peyman^ORCID,Halbout Philippe,Hiligsmann Mickaël^ORCID,Kanis John A.^ORCID,McCloskey Eugene V.^ORCID,Ormarsdottir Sif,Prieto-Alhambra Daniel,Radermecker Régis P.^ORCID,Rizzoli René^ORCID,Al-Saleh Yousef^ORCID,Silverman Stuart L.,Simon Lee S.^ORCID,Thomasius Friederike,van Staa Tjeerd^ORCID,Laslop Andrea,Cooper Cyrus^ORCID,Harvey Nicholas C.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

https://link.springer.com/content/pdf/10.1007/s00198-023-06827-2.pdf

Reference80 articles.

1. Kanis JA, Norton N, Harvey NC, Jacobson T, Johansson H, Lorentzon M et al (2021) SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos 16(1):82. https://doi.org/10.1007/s11657-020-00871-9

2. Odén A, McCloskey EV, Kanis JA, Harvey NC, Johansson H (2015) Burden of high fracture probability worldwide: secular increases 2010–2040. Osteoporos Int 26(9):2243–2248. https://doi.org/10.1007/s00198-015-3154-6

3. Söreskog E, Borgström F, Shepstone L, Clarke S, Cooper C, Harvey I et al (2020) Long-term cost-effectiveness of screening for fracture risk in a UK primary care setting: the SCOOP study. Osteoporos Int 31(8):1499–1506. https://doi.org/10.1007/s00198-020-05372-6

4. Chotiyarnwong P, McCloskey EV, Harvey NC, Lorentzon M, Prieto-Alhambra D, Abrahamsen B et al (2022) Is it time to consider population screening for fracture risk in postmenopausal women? A position paper from the International Osteoporosis Foundation Epidemiology/Quality of Life Working Group. Arch Osteoporos 17(1):87. https://doi.org/10.1007/s11657-022-01117-6

5. Lai F, Pei L, Chen X, Li J (2021) Osteoporosis-related randomized clinical trials with middle-aged and older adults registered on the International Clinical Trials Registry Platform. Front Endocrinol. 12:702261. https://doi.org/10.3389/fendo.2021.702261

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transparency in the secondary use of health data: Assessing the status quo of guidance and best practices;2024-08-11

2. Real-World Evidence to Support the Registration of a New Osteoporosis Medicinal Product in Europe;Therapeutic Innovation & Regulatory Science;2024-02-10

3. Domestic fall – related multiple osteoporotic vertebral fractures: considerations amid late COVID-19 pandemic (a case on point);Balneo and PRM Research Journal;2023-12-20